CryoLife, Inc.

CryoLife, Inc.

CryoLife, Inc.

Overview
Date Founded

1984

Headquarters

1655 Roberts Boulevard NW,Kennesaw, GA 30144-3632

Type of Company

Public

Employees (Worldwide)

1,100

Industries

Medical Products & Equipment
Medical Support Services
Hospitals & Patient Services
Appliances & Electronics
Computer Software

Company Description

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the Medical Devices, and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products; On-X products; CardioGenesis cardiac laser therapy; PerClot; and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Contact Data
Trying to get in touch with decision makers at CryoLife, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Executive Vice President, Chief Operating Officer & Chief Financial Officer

Vice President & General Counsel

Senior Vice President, General Counsel, Chief Compliance Officer & Secretary

Director, Marketing

Senior Vice President-Global Sales & Marketing

Vice President, Clinical Research

Co-Founder

GM of Cryolife Asia Pacific Private Ltd

Materials Coordinator

Board of Directors

Chairman, President & Chief Executive Officer at CryoLife, Inc.

Chief Executive Officer at Yale-New Haven Hospital, Inc.

Former Vice Chairman, Investment Banking at Piper Jaffray Cos.

Former Senior Vice President, Chief Financial Officer, Secretary at Charles River Laboratories, Inc.

Owner at Ronald D. Mccall PA

Former Managing Director at Bentley Associates LP

Chief Technology Officer-Fresenius Medical Care North America at Fresenius Medical Care Holdings, Inc.

Treasurer at STARR Life Sciences Corp.

President & Chief Executive Officer at Zyga Technology, Inc.

Paths to CryoLife, Inc.
Potential Connections via
Relationship Science
You
CryoLife, Inc.
Owners & Shareholders
Details Hidden

Thomson Horstmann & Bryant (THB) specializes in providing investment advisory services with respect to the smaller capitalization range of the US equity market. The firm manages portfolios in a Core-with-a-Value Bias style that focuses on quality and growth. They strive to identify companies early on when they are still priced at reasonable valuations. Their investment decision process begins by employing screens of companies within the small/micro-cap universe. Several fundamental valuation techniques reduce the preliminary screen to potential companies for investment. THB looks for companies with a relatively low p/e multiple and institutional under-ownership. THB's advice is limited to the following smaller company strategies: Micro-Cap, Small-Cap Core, Small-Cap Value, Small-Cap II, and Mid-Cap.

Details Hidden

Elk Creek Partners specialize in making growth-oriented investments in publicly-traded stocks of small- and medium-sized companies. The firm offers investment advisory services for specific strategies, including Small-Cap Growth, Mid-Cap Growth and SMID-Cap Growth. Elk Creek Partners works with clients to establish investment objectives based on their unique circumstances. The key elements of the firm's investment approach are growth company identification, fundamental research, valuation analysis, and portfolio construction.The firm's Small-Cap Growth strategy is based on a fundamental, stock-by-stock approach. The portfolio is concentrated in stocks purchased with a market-cap generally of $500 million to $5 billion and with portfolio characteristics similar to the Russell 2000 Growth Index. They target companies with sustained growth and which have products and/or services that are market-share takers.Elk Creek's SMID-Cap Growth strategy is a direct extension of the Small-Cap strategy. The SMID Cap Growth strategy concentrates in stocks with a market-cap of $1 billion to $10 billion and with portfolio characteristics similar to the Russell 2500 Growth Index. The process implemented in the SMID-Cap strategy is the same as the Small-Cap strategy in both buying and selling individual stocks.The firm's Mid-Cap Growth strategy is a direct extension of the Small- and SMID-Cap Growth strategies. The Mid-Cap Growth strategy concentrates in stocks with a market-cap of $2 billion to $12 billion and with portfolio characteristics similar to the Russell Mid-Cap Growth Index. The process implemented in the Mid-Cap strategy is the same as the Small-Cap strategy in both buying and selling individual stocks. ^

Details Hidden

Next Century Growth Investors's investment products focus on investing in companies the firm believes have substantial potential for high long-term growth. They seek to identify the fastest growing and highest quality companies for investment through a fundamentals-based bottom-up approach. Next Century Strong seeks to invest in the securities of companies with strong revenue growth, large growing market opportunities, market leading positions, control of distribution, and strong management. Their investment strategies include: Small Cap Ultra, Small Cap, Small/Mid-Cap (SMID), Large Cap, All Cap, Focused Mid-Cap, and Small/Micro.

Recent Transactions
Details Hidden

CryoLife, Inc. purchases JOTEC GmbH

Details Hidden

CryoLife, Inc. purchases Genesee Biomedical, Inc. /Photofix Product Line from Genesee BioMedical, Inc.

Details Hidden

Merit Medical Systems, Inc. purchases Cryolife, Inc. /Hero Graft Brand from CryoLife, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onCryoLife, Inc. purchases On-X Life Technologies, Inc. from Paul Capital Partners LP, PTV Sciences LP

Accountant

Advised onCryoLife, Inc. purchases Ideas for Medicine, Inc.

Escrow Agent

Advised onCryoLife, Inc. purchases JOTEC GmbH

Legal Advisor

Advised onCryoLife, Inc. purchases JOTEC GmbH

Counsel

Advised onCryoLife, Inc. purchases JOTEC GmbH

Associate

Advised onCryoLife, Inc. purchases JOTEC GmbH

Advisors & Consultants
Advisor

Partner at Faegre Baker Daniels LLP

Key Stats and Financials As of 2018
Market Capitalization
$1.1B
Total Enterprise Value
$1.21B
Earnings Per Share
$-0.08
Revenue
$263M
Net Profit
$-2.81M
Total Equity
$275M
EBITDAMargin
13.62%
Enterprise Value EBITDAOperating
33.92x
TEVNet Income
-431.81x
Debt TEV
0.18x
Enterprise Value Sales
4.62x
Total Debt
$224M
EBITDA
$35.8M
Five Year Compounded Annual Growth Rate Of Revenue
13.3%
Three Year Compounded Annual Growth Rate Of Revenue
21.68%
Political Donations
$5,000
2002
Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Becton, Dickinson & Co. Medical Products & Equipment - Franklin Lakes, New Jersey

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CryoLife, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CryoLife, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CryoLife, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/cryolife-inc-18027
  • https://relationshipscience.com/organization/cryolife-inc-18027